Loading Now

Summary of Machine Learning Classification Of Alzheimer’s Disease Stages Using Cerebrospinal Fluid Biomarkers Alone, by Vivek Kumar Tiwari et al.


Machine Learning Classification of Alzheimer’s Disease Stages Using Cerebrospinal Fluid Biomarkers Alone

by Vivek Kumar Tiwari, Premananda Indic, Shawana Tabassum

First submitted to arxiv on: 2 Jan 2024

Categories

  • Main: Machine Learning (cs.LG)
  • Secondary: Quantitative Methods (q-bio.QM); Applications (stat.AP)

     Abstract of paper      PDF of paper


GrooveSquid.com Paper Summaries

GrooveSquid.com’s goal is to make artificial intelligence research accessible by summarizing AI papers in simpler terms. Each summary below covers the same AI paper, written at different levels of difficulty. The medium difficulty and low difficulty versions are original summaries written by GrooveSquid.com, while the high difficulty version is the paper’s original abstract. Feel free to learn from the version that suits you best!

Summary difficulty Written by Summary
High Paper authors High Difficulty Summary
Read the original abstract here
Medium GrooveSquid.com (original content) Medium Difficulty Summary
Machine learning models have been used to classify different stages of Alzheimer’s disease based on cerebrospinal fluid biomarker levels. Researchers analyzed electronic health records from the National Alzheimer’s Coordinating Centre database and found that machine learning classifiers such as Ensemble Boosted Tree, Logistic Regression, and Ensemble Bagged Tree can accurately diagnose early-stage Alzheimer’s disease with high accuracy (up to 84.4%). These findings have the potential to aid clinicians in making informed decisions about diagnosis, monitoring, and intervention.
Low GrooveSquid.com (original content) Low Difficulty Summary
Alzheimer’s disease is a serious condition that affects millions of people worldwide. The key challenge is diagnosing it early enough to make a difference. Scientists have been searching for ways to do this using biomarkers found in cerebrospinal fluid (the liquid surrounding the brain). This study used machine learning models to analyze these biomarkers and predict which stage of Alzheimer’s someone has. The results show that certain models can accurately diagnose the disease at its early stages, giving doctors a powerful tool to help patients.

Keywords

* Artificial intelligence  * Logistic regression  * Machine learning